Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-10-16 | 2023-10-10 |
| Drug Identification Number | 02441608 | 02441608 |
| Brand name | ULTRA-TECHNEKOW V4 | ULTRA-TECHNEKOW V4 |
| Common or Proper name | Technetium Tc 99m generator (Sodium Pertechnetate Tc 99m Injection) | Technetium Tc 99m generator (Sodium Pertechnetate Tc 99m Injection) |
| Company Name | CURIUM CANADA INC | CURIUM CANADA INC |
| Ingredients | SODIUM PERTECHNETATE TC-99M | SODIUM PERTECHNETATE TC-99M |
| Strength(s) | 19CI | 19CI |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1-19 curies | 1-19 curies |
| ATC code | V09FX | V09FX |
| ATC description | ||
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2023-10-10 | 2023-10-10 |
| Actual start date | 2023-10-12 | 2023-10-12 |
| Estimated end date | 2023-10-12 | 2023-10-12 |
| Actual end date | 2023-10-14 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Due to all approved reactors being on maintenance, we will not have molybdenum from an approved source for the run of 10OCt shipping on 11OCT. We will be back to normal on 12OCT run. | Due to all approved reactors being on maintenance, we will not have molybdenum from an approved source for the run of 10OCt shipping on 11OCT. We will be back to normal on 12OCT run. |
| Health Canada comments |